Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor Treatment
Study limitation reported by the research below: “The mechanism by which tumors may drive anti-PLA2R antibody production is not fully established, adding biological uncertainty to the clinical conclusions.”